GoodRx Holdings (GDRX) Non-cash Items (2020 - 2024)

GoodRx Holdings has disclosed Non-cash Items across 5 years of filings, most recently posting $4.4 million for Q4 2024.

• Non-cash Items for Q4 2024 came in at $4.4 million, up 21363.41% year-over-year; the trailing twelve-month figure through Dec 2024 was $4.4 million (up 21363.41% YoY), and the FY2024 annual result was $4.4 million, up 21363.41% from the prior year.
• Non-cash Items came in at $4.4 million for Q4 2024 at GoodRx Holdings, up from $20500.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $1.2 billion in Q3 2020 to a low of $20500.0 in Q4 2023.
• The 5-year median for Non-cash Items is $49.7 million (2020), against an average of $243.9 million.
• Across the five-year window, Non-cash Items sank 99.99% in 2021 and surged 55932.48% in 2022, its largest moves.
• GoodRx Holdings' Non-cash Items stood at $341.9 million in 2020, then changed by 0.0% to $341.9 million in 2021, then tumbled by 92.72% to $24.9 million in 2022, then tumbled by 99.92% to $20500.0 in 2023, then surged by 21363.41% to $4.4 million in 2024.
• The last three Non-cash Items figures came in at $4.4 million (Q4 2024), $20500.0 (Q4 2023), and $24.9 million (Q4 2022), per Business Quant data.